2015 CompetitiveWatch: DuPont in the Global Agrochemical Industry - Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction

September 2015 | 59 pages | ID: C677819DFDBEN
Venture Planning Group

Abstracts

This strategic assessment of DuPont, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from VPGMarketResearch presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global agrochemical market. SECTION I: EXECUTIVE SUMMARYA 3-5 page synopsis of key sections. SECTION II: BUSINESS ORGANIZATIONHistory of the companys agrochemical business evolution, which is important to understandingthe corporate culture, management mentality and strategies. Recent acquisitions, divestitures and major organizational changes. Current organizational structure. SECTION III: SENIOR MANAGEMENTNames, titles and background of key executives. SECTION IV: FACILITIES AND EMPLOYEESAdministrative, manufacturing and R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. The U.S. and international work force size and distribution. SECTION V: TECHNOLOGICAL KNOW-HOWInternally developed and acquired agrochemical and related capabilities. Proprietary technologies and patent litigation. SECTION VI: PRODUCT PORTFOLIOReview of major product lines. Applications, advantages and weaknesses of leading products. SECTION VII: MARKETING TACTICSPromotional tactics. Distribution approaches. Product service and support. Customer relations. SECTION VIII: FINANCIAL ANALYSISEstimated sales by division, geographic region and product line. Five-year sales and operating profit performance. SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMSEstimated R&D budget. Research facilities and staff. New technologies, products and applications in development. SECTION X: COLLABORATIVE ARRANGEMENTSJoint ventures, distribution, O. E. M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. SECTION XI: STRATEGIC DIRECTIONSpecific business, new product development and marketing strategies. Anticipated acquisitions, joint ventures and divestitures. Contains 59 pages and 7 tables

Contents

LIST OF TABLES

INFECTIOUS DISEASE TESTING MARKET

Grifols US EBV Testing Market Diagnostics Sales by Major Supplier

MOLECULAR DIAGNOSTIC TESTING MARKET

Grifols France HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
Grifols Germany HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Grifols Italy HIV/Hepatitis NAT Market by Major Supplier
Grifols Japan HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Grifols Spain HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Grifols UK HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Grifols US HIV/Hepatitis NAT Market Reagent Sales By Major Supplier

BLOOD BANKING TESTING MARKET

Grifols France HIV/Hepatitis NAT Screening Market Reagent Sales by Major Supplier
Grifols Germany HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Grifols Italy HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Grifols Spain Major Suppliers of Blood Typing and Grouping Reagents Sales and Market Shares
Grifols Spain HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Grifols UK HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Grifols US HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Grifols US West Nile Virus NAT Market Reagent Sales by Major Supplier